I. Hirsch

Irl B Hirsch, Timothy S Bailey, Lois Jovanovič, 2015, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Human Insulin for Type 2 Diabetes: An Effective, Less-Expensive Option.

I. Hirsch, K. Lipska, M. Riddle, 2017, Journal of the American Medical Association (JAMA).

New Insulin Delivery Recommendations.

I. Hirsch, B. Bode, G. Grassi, 2016, Mayo Clinic proceedings.

Low glucose suspend: ready for prime time?

Irl B Hirsch, I. Hirsch, 2012, Diabetes technology & therapeutics.

An endocrinologist's view on the practical use of insulin

I. Hirsch, 2006 .

Treatment of patients with severe insulin deficiency; what we have learned over the past 2 years.

Irl B Hirsch, I. Hirsch, 2004, The American journal of medicine.

The Effect of Glucose Variability on the Risk of Microvascular Complications in Type 1 Diabetes

Michael Brownlee, Irl B Hirsch, I. Hirsch, 2007, Diabetes Care.

Continuous glucose monitoring and intensive treatment of type 1 diabetes.

Michael O'Grady, Howard Wolpert, Bruce W Bode, 2008, The New England journal of medicine.

Sensor-augmented insulin pump therapy: results of the first randomized treat-to-target study.

Christopher G. Parkin, Bruce A. Buckingham, Irl B. Hirsch, 2008, Diabetes technology & therapeutics.

American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control.

Richard Hellman, Silvio E. Inzucchi, Irl B. Hirsch, 2009, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Self-Monitoring of Blood Glucose (SMBG) in insulin- and non-insulin-using adults with diabetes: consensus recommendations for improving SMBG accuracy, utilization, and research.

Bruce W Bode, Irl B Hirsch, I. Hirsch, 2008, Diabetes technology & therapeutics.

Recommendations for Standardizing Glucose Reporting and Analysis to Optimize Clinical Decision Making in Diabetes: The Ambulatory Glucose Profile

David C Klonoff, Bruce Buckingham, Irl B Hirsch, 2013, Journal of diabetes science and technology.

Outpatient insulin therapy in type 1 and type 2 diabetes mellitus: scientific review.

I. Hirsch, D. Dewitt, D. DeWitt, 2003, JAMA.

International Consensus on Use of Continuous Glucose Monitoring

Eyal Dassau, Claudio Cobelli, Roman Hovorka, 2017, Diabetes Care.

A Pilot Study of the Feasibility and Accuracy of Inpatient Continuous Glucose Monitoring

D. Flum, I. Hirsch, G. A. Rooke, 2020, Diabetes Care.

Inpatient management of adults and children with type 1 diabetes.

I. Hirsch, David Tridgell, A. Tridgell, 2010, Endocrinology and metabolism clinics of North America.

The Death of the “1800-Calorie ADA Diet”

I. Hirsch, 2002 .

View 2 Sliding Scale or Sliding Scare: It's All Sliding Nonsense

I. Hirsch, R. Farkas, 2001 .

Sliding scale insulin use and rates of hyperglycemia.

I. Hirsch, B. Gaster, 1998, Archives of internal medicine.

The Evolution of Insulin and How it Informs Therapy and Treatment Choices

J. M. Beals, I. Hirsch, J. Beals, 2020, Endocrine reviews.

Flash Continuous Glucose Monitoring: Implications for Use of Continuous Data in Daily Diabetes Management

I. Hirsch, C. A. Verderese, Elizabeth Nardacci, 2019, Diabetes Spectrum.

Using Flash Continuous Glucose Monitoring in Primary Practice

I. Hirsch, E. Wright, 2018, Clinical Diabetes.

PROFESSIONAL FLASH CONTINUOUS GLUCOSE MONITORING WITH AMBULATORY GLUCOSE PROFILE REPORTING TO SUPPLEMENT A1C: RATIONALE AND PRACTICAL IMPLEMENTATION.

I. Hirsch, C. A. Verderese, 2017, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Plasmapheresis and immunosuppression in stiff-man syndrome with type 1 diabetes: a 2-year study

I. Hirsch, C. Davis, Å. Lernmark, 1999, Journal of Neurology.

The changing faces of diabetes.

I. Hirsch, 2003, Primary care.

Blood glucose monitoring technology: translating data into practice.

I. Hirsch, 2004, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Advances in Glucose Monitoring and Automated Insulin Delivery: Supplement to Endocrine Society Clinical Practice Guidelines

I. Hirsch, A. Ahmann, A. Peters, 2018, Journal of the Endocrine Society.

Summaries of Symposia Conducted in Conjunction with the 19th Annual Meeting and Clinical Congress of the American Association of Clinical Endocrinologists

P. Raskin, R. DeFronzo, I. Hirsch, 2010 .

Use of serum and plasma glucose measurements as a benchmark for improved hospital-wide glycemic control.

I. Hirsch, A. Hoofnagle, G. Peterson, 2008, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

W. E. Sanabria, John A. Hamling, Ju Han Kim, 2019, The Lancet.

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial.

W. E. Sanabria, John A. Hamling, Ju Han Kim, 2019, Lancet.

Prevalence of SGLT2i and GLP1RA use among US adults with type 2 diabetes.

I. D. de Boer, I. Hirsch, K. Tuttle, 2022, Journal of diabetes and its complications.

Availability and Affordability of Essential Medicines: Implications for Global Diabetes Treatment

I. Hirsch, K. Lipska, J. Yudkin, 2018, Current Diabetes Reports.

Hypoglycemia in Older Adults with Type 1 Diabetes.

R. Beck, I. Hirsch, J. Largay, 2016, Diabetes technology & therapeutics.

Islet cell antibodies and glutamic acid decarboxylase antibodies, but not the clinical phenotype, help to identify type 1(1/2) diabetes in patients presenting with type 2 diabetes.

I. Hirsch, C. Greenbaum, R. Naik, 2001, Metabolism: clinical and experimental.

How to best manage glycemia and non-glycemia during the time of acute myocardial infarction.

I. Hirsch, K. O’Brien, 2012, Diabetes technology & therapeutics.

Integrating Continuous Glucose Monitoring Into Clinical Practices and Patients' Lives.

I. Hirsch, E. Miller, Eden M. Miller, 2021, Diabetes technology & therapeutics.

Optimizing Postprandial Glucose Management in Adults With Insulin-Requiring Diabetes: Report and Recommendations

A. McCall, J. McGill, J. Leahy, 2019, Journal of the Endocrine Society.

Need for Regulatory Change to Incorporate Beyond A1C Glycemic Metrics

A. McCall, R. Beck, Aaron J. Kowalski, 2018, Diabetes Care.

Role of Continuous Glucose Monitoring in Diabetes Treatment

I. Hirsch, R. Bergenstal, T. Battelino, 2018 .

Intraoperative blood glucose management: impact of a real-time decision support system on adherence to institutional protocol

I. Hirsch, H. Schwid, B. Nair, 2016, Journal of Clinical Monitoring and Computing.

Insulin and glucagon in prevention of hypoglycemia during exercise in humans.

I. Hirsch, P. Cryer, C. Parvin, 1991, The American journal of physiology.

Catecholamines in prevention of hypoglycemia during exercise in humans.

I. Hirsch, P. Cryer, C. Parvin, 1991, The American journal of physiology.

PERL in Diabetes Study : A Randomized Double-Blinded Trial of Allopurinol d Rationale , Design , and Baseline Data

J. McGill, I. D. de Boer, A. Galecki, 2019 .

Weight and elevated albumin to creatinine ratio in youth with diabetes: the SEARCH for Diabetes in Youth study

D. Maahs, I. Hirsch, B. Snively, 2008, Pediatric Nephrology.

Management of Hyperglycemia in Hospitalized Adult Patients in Non-Critical Care Settings: An Endocrine Society Clinical Practice Guideline.

I. Hirsch, R. Muniyappa, G. Umpierrez, 2022, The Journal of clinical endocrinology and metabolism.

Evidence-Based or Hassle-Based Medicine?

I. Hirsch, 2001 .

Application of Glycemic Variability Percentage: Implications for Continuous Glucose Monitor Utilization and Analysis of Artificial Pancreas Data.

B. Buckingham, I. Hirsch, T. Peyser, 2017, Diabetes technology & therapeutics.

Who will manage American patients with diabetes? Residents' career preferences and perceptions of diabetes care.

J. Close, I. Hirsch, K. Close, 2011, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Understanding Clinical Research

I. Hirsch, 2001 .

Diabetes and CKD in the United States Population, 2009-2014.

P. Heagerty, B. Kestenbaum, C. Robinson-Cohen, 2017, Clinical journal of the American Society of Nephrology : CJASN.

Temporal Relationship of Glycemia With Cardiac Arrhythmias in Patients With Type 2 Diabetes and CKD.

I. D. de Boer, I. Hirsch, N. Bansal, 2020, American Journal of Kidney Diseases.

Effect of liraglutide on markers of insulin production in persons with type 2 diabetes treated with multiple daily insulin injections.

J. Tuomilehto, I. Hirsch, M. Wijkman, 2021, Journal of diabetes and its complications.

Effect of liraglutide on anthropometric measurements, sagittal abdominal diameter and adiponectin levels in people with type 2 diabetes treated with multiple daily insulin injections: evaluations from a randomized trial (MDI‐liraglutide study 5)

J. Tuomilehto, I. Hirsch, T. Gustafsson, 2019, Obesity science & practice.

Continuous Glucose Monitoring and Use of Alternative Markers To Assess Glycemia in Chronic Kidney Disease

I. D. de Boer, I. Hirsch, R. Little, 2020, Diabetes Care.

Understanding low sugar from NICE-SUGAR.

I. Hirsch, 2012, The New England journal of medicine.

American College of Endocrinology position statement on inpatient diabetes and metabolic control.

I. Hirsch, A. Garber, R. Cobin, 2004, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Blood glucose control using a computer-guided glucose management system in allogeneic hematopoietic cell transplant recipients

M. Bar, I. Hirsch, R. Farah, 2016, Bone Marrow Transplantation.

Ascorbic acid clearance in diabetic nephropathy.

I. Hirsch, A. Chait, D. Atchley, 1998, Journal of diabetes and its complications.

Insulin analogues [5] (multiple letters)

I. Hirsch, M. Marcovecchio, F. Chiarelli, 2005 .

Decisional practices and patterns of intraoperative glucose management in an academic medical center.

Gail A. Van Norman, I. Hirsch, H. Schwid, 2016, Journal of clinical anesthesia.

Use of Personal Continuous Glucose Monitoring Device Is Associated With Reduced Risk of Hypoglycemia in a 16-Week Clinical Trial of People With Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion

O. Hejlesen, I. Hirsch, P. Vestergaard, 2020, Journal of diabetes science and technology.

Role of Continuous Glucose Monitoring (CGM) in Clinical Trials: Recommendations on Reporting Short running title: CGM in Trials: reporting recommendations

K. Barnard, W. Polonsky, I. Hirsch, 2017 .

The burden of diabetes (care).

I. Hirsch, 2003, Diabetes care.

Piecing the puzzle together: ACCORDing to whom?

I. Hirsch, 2008, The Journal of clinical endocrinology and metabolism.

Does Time-in-Range Matter? Perspectives From People With Diabetes on the Success of Current Therapies and the Drivers of Improved Outcomes

I. Hirsch, K. Close, B. Levine, 2017, Clinical Diabetes.

What's in a name: latent autoimmune diabetes of adults, type 1.5, adult-onset, and type 1 diabetes.

I. Hirsch, J. Palmer, 2003, Diabetes care.

The Question Is Answered: Now what?

I. Hirsch, R. Farkas-Hirsch, 1994, Diabetes Care.

Evidence-based management: using serial firm trials to improve diabetes care quality.

I. Hirsch, S. Ramsey, A. Cheadle, 2002, The Joint Commission journal on quality improvement.

Isn’t This Just Bedtime Snacking?

W. Katon, I. Hirsch, P. Ciechanowski, 2006, Diabetes Care.

A multifaceted intervention in support of diabetes treatment guidelines: a cont trial.

I. Hirsch, S. Ramsey, A. Cheadle, 2002, Diabetes research and clinical practice.

Diabetes care entering 2015: ineffective ranting.

I. Hirsch, 2015, Diabetes technology & therapeutics.

Approach to the patient with diabetes undergoing a vascular or interventional procedure.

I. Hirsch, 1997, Journal of vascular and interventional radiology : JVIR.

The effect of ejaculation on albumin excretion rate.

I. Hirsch, J. Skyler, R. Farkas-Hirsch, 1992, Journal of diabetes and its complications.

Insulin treatment for type 2 diabetes.

I. Hirsch, B. Gaster, T. Evans, 1998, JAMA.

“Seeing” Between the Lines

I. Hirsch, 2001 .

Glycemic control and complications of diabetes mellitus.

I. Hirsch, 1995, The Western journal of medicine.

Inpatient diabetes: review of data from the cardiac care unit.

I. Hirsch, 2006, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Severe insulin resistance in a patient with type 1 diabetes and stiff-man syndrome treated with insulin lispro.

I. Hirsch, A. Chait, D. D’Alessio, 1998, Diabetes research and clinical practice.

Blood glucose targets in the critically ill: is one size fits all still appropriate?

I. Hirsch, G. Umpierrez, M. Schwartz, 2022, The Lancet Diabetes & Endocrinology.

A Pragmatic Approach to Inpatient Diabetes Management during the COVID-19 Pandemic

I. Hirsch, R. Muniyappa, R. Rushakoff, 2020, The Journal of clinical endocrinology and metabolism.

Sepsis and glycemia: read the fine print!

I. Hirsch, 2008, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Evidence-based priming.

I. Hirsch, 2006, Diabetes technology & therapeutics.

Failure of Nocturnal Hypoglycemia to Cause Daytime Hyperglycemia in Patients With IDDM

I. Hirsch, P. Cryer, L. Smith, 1990, Diabetes Care.

Self-monitoring of blood glucose.

I. Hirsch, S. Garg, 2015, Diabetes technology & therapeutics.

Pulmonary edema associated with troglitazone therapy.

I. Hirsch, J. Kelly, S. Cooper, 1999, Archives of internal medicine.

The Management of Type 1 Diabetes in Adults. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

I. Hirsch, E. Renard, T. Klupa, 2021, Diabetes Care.

Relative Hypoglycemia and Lower Hemoglobin A1c-Adjusted Time in Band Are Strongly Associated With Increased Mortality in Critically Ill Patients

I. Hirsch, G. Umpierrez, M. Brownlee, 2022, Critical care medicine.

The First Hybrid Closed-Loop Insulin Pump: Will It Meet Its Potential?

I. Hirsch, 2017, Diabetes technology & therapeutics.

The rationale and management of hyperglycemia for in-patients with cardiovascular disease: time for change.

Irl B Hirsch, I. Hirsch, D. Trence, 2003, The Journal of clinical endocrinology and metabolism.

Another Rant About Sliding Scale Insulin

I. Hirsch, 2011 .

Insulin Therapy for Diabetes: Is the Future Now?

I. Hirsch, 2001 .

The Future of the GLP-1 Receptor Agonists.

I. Hirsch, 2019, JAMA.

The Challenge of the Use of Glycemic Biomarkers in Diabetes: Reflecting on Hemoglobin A1C, 1,5-Anhydroglucitol, and the Glycated Proteins Fructosamine and Glycated Albumin

I. Hirsch, L. Wright, 2012, Diabetes Spectrum.

Unknown Safety and Efficacy of Smartphone Bolus Calculator Apps Puts Patients at Risk for Severe Adverse Outcomes

I. Hirsch, C. Parkin, 2016, Journal of diabetes science and technology.

AACE comprehensive diabetes management algorithm 2013.

J. McGill, I. Hirsch, G. Grunberger, 2013, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Variables associated with insulin production in persons with type 2 diabetes treated with multiple daily insulin injections.

J. Tuomilehto, I. Hirsch, Henrik Imberg, 2020, Primary care diabetes.

The Impact of Inpatient Point‐Of‐Care Blood Glucose Quality Control Testing

I. Hirsch, J. Whitney, A. Hoofnagle, 2011, Journal for Healthcare Quality.

Hypoglycemia and the hypoglycemic unawareness syndrome.

I. Hirsch, 2000, Diabetes technology & therapeutics.

American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control.

Mary T Korytkowski, Richard Hellman, Irl B Hirsch, 2009, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Acute and Chronic Glucose Control in Critically Ill Patients With Diabetes: The Impact of Prior Insulin Treatment

I. Hirsch, G. Umpierrez, M. Brownlee, 2021, Journal of diabetes science and technology.

Fifteen-minute Frequency of Glucose Measurements and the Use of Threshold Alarms: Impact on Mitigating Dysglycemia in Critically Ill Patients

S. Nasraway, I. Hirsch, G. Bochicchio, 2019, Journal of diabetes science and technology.

Visceral obesity, hepatic lipase activity, and dyslipidemia in type 1 diabetes.

I. Hirsch, J. Brunzell, J. Palmer, 2003, The Journal of clinical endocrinology and metabolism.

Impact of the 2013 National Rollout of CMS Competitive Bidding Program: The Disruption Continues

D. Marrero, I. Hirsch, C. Parkin, 2017, Diabetes Care.

High titers of autoantibodies to glutamate decarboxylase in type 1 diabetes patients: epitope analysis and inhibition of enzyme activity.

I. Hirsch, B. Ransom, M. Maitland, 2013, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Diabetic Kidney Disease: A Report From an ADA Consensus Conference

Mark E Molitch, Irl B Hirsch, Kamyar Kalantar-Zadeh, 2014, Diabetes Care.

American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update.

Sandra L. Weber, J. McGill, R. DeFronzo, 2022, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Physicians' Practices in Screening for the Development of Diabetic Nephropathy and the Use of Glycosylated Hemoglobin Levels

I. Hirsch, K. Miller, K. Miller, 1994, Diabetes Care.

Safety and efficacy of insulin degludec/insulin aspart with bolus mealtime insulin aspart compared with standard basal–bolus treatment in people with Type 1 diabetes: 1–year results from a randomized clinical trial (BOOST ® T1)

I. Hirsch, K. Hermansen, E. Franek, 2016, Diabetic medicine : a journal of the British Diabetic Association.

A new look at brittle diabetes☆

I. Hirsch, L. Gaudiani, 2020, Journal of Diabetes and its Complications.

Assessment of therapy with continuous subcutaneous insulin infusion in an academic diabetes clinic.

I. Hirsch, J. Rudolph, 2002, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

1,5-ANHYDROGLUCITOL AND NEONATAL COMPLICATIONS IN PREGNANCY COMPLICATED BY DIABETES.

I. Hirsch, T. Gooley, Z. Brown, 2015, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Insulin resistance as an adverse effect of leuprolide and bicalutamide treatment.

I. Hirsch, M. Paniagua, 2005, The journals of gerontology. Series A, Biological sciences and medical sciences.

Improving the quality of outpatient care for older patients with diabetes: lessons from a comparison of rural and urban communities.

I. Hirsch, R. Rosenblatt, L. Hart, 2001, The Journal of family practice.

Arguments against the use of inhaled insulin.

I. Hirsch, 2007, Diabetes technology & therapeutics.

Hypoglycemia prevention and user acceptance of an insulin pump system with predictive low glucose management

B. Davis, I. Hirsch, D. Lai, 2017 .

Erratum: Management of diabetes and hyperglycemia in hospitals (Technical Review) (Diabetes Care (2004) 27 (553-591))

I. Hirsch, A. Ahmann, S. Braithwaite, 2004 .

The Glycemic Ratio Is Strongly and Independently Associated With Mortality in the Critically Ill.

I. Hirsch, G. Umpierrez, M. Brownlee, 2022, Journal of diabetes science and technology.

How Introduction of Automated Insulin Delivery Systems May Influence Psychosocial Outcomes in Adults with Type 1 Diabetes: Findings from the First Investigation with the Omnipod® 5 System.

Lauren M. Huyett, W. Polonsky, I. Hirsch, 2022, Diabetes research and clinical practice.

Anti–PD-1 and Anti–PDL-1 Monoclonal Antibodies Causing Type 1 Diabetes

W. Hagopian, I. Hirsch, J. Palmer, 2015, Diabetes Care.

Metformin added to insulin therapy in poorly controlled type 2 diabetes.

I. Hirsch, 1999, Diabetes care.

PROGRESSION TO INSULIN DEPENDENCE POST-TREATMENT WITH IMMUNE CHECKPOINT INHIBITORS IN PRE-EXISTING TYPE 2 DIABETES

I. Hirsch, Zona Batacchi, L. Wright, 2017 .

Management of the Diabetic Patient

I. Hirsch, 1996 .

Insulin therapy: evolution and practice.

I. Hirsch, 2007, Endocrinology and metabolism clinics of North America.

HbA1c and Glucose Management Indicator Discordance: A Real-World Analysis.

I. Hirsch, T. Gooley, Jordan E Perlman, 2020, Diabetes technology & therapeutics.

Type I diabetes and insulin therapy.

I. Hirsch, R. Farkas-Hirsch, Irl B Hirsch, 1993, The Nursing clinics of North America.

New Medications for the Treatment of Diabetes.

I. Hirsch, S. Garg, Scott J. Brackett, 2020, Diabetes technology & therapeutics.

NAFLD/NASH and Diabetes.

I. Hirsch, S. Garg, K. Garg, 2020, Diabetes technology & therapeutics.

Smoking is Associated With Increased Risk of Not Achieving Glycemic Target, Increased Glycemic Variability, and Increased Risk of Hypoglycemia for People With Type 1 Diabetes

O. Hejlesen, E. Seto, I. Hirsch, 2020, Journal of diabetes science and technology.

Treatment of LADA With Etanercept

I. Hirsch, V. Montes, 2012, Diabetes Care.

Cushing syndrome due to surreptitious glucocorticoid administration.

I. Hirsch, S. Quddusi, B. Toivola, 1998, Archives of internal medicine.

International Comparison of Smoking and Metabolic Control in Patients With Type 1 Diabetes

D. Maahs, I. Hirsch, M. Riedl, 2016, Diabetes Care.

Transition of Patients to and from Insulin Degludec: A Clinical Challenge.

I. Hirsch, B. Draznin, 2019, The Journal of clinical endocrinology and metabolism.

Diabetes and the WHO Model List of Essential Medicines.

I. Hirsch, F. Khan, Farah N. Khan, 2022, The lancet. Diabetes & endocrinology.

Driving Safety in Adolescents and Young Adults With Type 1 Diabetes

I. Hirsch, J. Yi-Frazier, Kendra L. Read, 2020, Diabetes Spectrum.

Reduced Plasma Peroxyl Radical Trapping Capacity and Increased Susceptibility of LDL to Oxidation In Poorly Controlled IDDM

I. Hirsch, A. Chait, J. Brunzell, 1994, Diabetes.

Improving Patient Experience With Insulin Infusion Sets

Alison B. Evert, B. Buckingham, I. Hirsch, 2016, The Diabetes educator.

A Practical Approach to Using Trend Arrows on the Dexcom G5 CGM System for the Management of Adults With Diabetes

Ruth S. Weinstock, Dennis R Harris, Irl B. Hirsch, 2017, Journal of the Endocrine Society.

Role of Orlistat in the Treatment of Obese Patients With Type 2 Diabetes: A 1-year randomized double-blind study

Roy A Kaplan, J. McGill, I. Hirsch, 1998, Diabetes Care.

The relationship between hypoglycaemia and glucose variability in type 1 diabetes

I. Hirsch, Jordan E Perlman, T. Gooley, 2021, Diabetes, obesity & metabolism.

Real-Time Continuous Glucose Monitoring During the Coronavirus Disease 2019 Pandemic and Its Impact on Time in Range

Joost H. van der Linden, I. Hirsch, S. Garg, 2021, Diabetes Technology & Therapeutics.

The Digital/Virtual Diabetes Clinic - the Future is Now. Recommendations from an International Panel on Diabetes Digital Technologies Introduction.

V. Mohan, L. Heinemann, I. Hirsch, 2020, Diabetes technology & therapeutics.

Hitting the dartboard from 40,000 feet.

I. Hirsch, 2011, Diabetes technology & therapeutics.

Prolonged Nocturnal Hypoglycemia Is Common During 12 Months of Continuous Glucose Monitoring in Children and Adults With Type 1 Diabetes

Darrell M. Wilson, R. Beck, I. Hirsch, 2010, Diabetes Care.

Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomized Clinical Trial

Sofia Dahlqvist, Marcus Lind, Anders Frid, 2017, JAMA.

Higher glycemic thresholds for symptoms during beta-adrenergic blockade in IDDM.

I. Hirsch, P. Cryer, S. Craft, 1991, Diabetes.

Editorial: INSULIN PUMP THERAPY: NO LONGER A FAD

I. Hirsch, 2000 .

Ranting in 2019: Are Things Improving?

I. Hirsch, 2019, Diabetes technology & therapeutics.

Correction to: The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

I. Hirsch, E. Renard, T. Klupa, 2021, Diabetologia.

Response to Letter to the Editor: “Trends in Endocrinology Fellowship Recruitment: Reasons for Concern and Possible Interventions”

I. Hirsch, R. Gabbay, G. Romeo, 2020, The Journal of clinical endocrinology and metabolism.

Liraglutide in people treated for type 2 diabetes with multiple daily insulin injections: randomised clinical trial (MDI Liraglutide trial)

J. Tuomilehto, I. Hirsch, B. Ahrén, 2015, BMJ : British Medical Journal.

Hypoglycemia in Adults With Cystic Fibrosis During Oral Glucose Tolerance Testing

C. Goss, I. Hirsch, M. Aitken, 2013, Diabetes Care.

REPLACE-BG: A Randomized Trial Comparing Continuous Glucose Monitoring With and Without Routine Blood Glucose Monitoring in Well-Controlled Adults With Type 1 Diabetes

Rodica Pop-Busui, Michael R. Rickels, Elena Toschi, 2017 .

CONTINUOUS GLUCOSE MONITORING: A CONSENSUS CONFERENCE OF THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY.

Irl B Hirsch, Timothy S Bailey, Henry Anhalt, 2016, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Response to Comment on Wong et al. Real-Time Continuous Glucose Monitoring Among Participants in the T1D Exchange Clinic Registry. Diabetes Care 2014;37:2702–2709

R. Beck, H. Chase, D. Maahs, 2015, Diabetes Care.

Baseline risk markers and visit-to-visit variability in relation to kidney outcomes - a post-hoc analysis of the PERL study.

J. McGill, I. D. de Boer, T. Hansen, 2022, Diabetes research and clinical practice.

AACE/ACE Consensus Statement CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM – 2018 EXECUTIVE SUMMARY

Irl B Hirsch, Janet B McGill, Lawrence Blonde, 2018 .

Assessment of Glucose Monitoring Adherence in Medicare Beneficiaries with Insulin-Treated Diabetes.

I. Hirsch, C. Parkin, Liou Xu, 2022, Diabetes technology & therapeutics.

Diabetic Kidney Disease: A Report From an ADA Consensus Conference

I. D. de Boer, G. Bakris, I. Hirsch, 2014, Diabetes Care.

Diabetic Kidney Disease: A Report From an ADA Consensus

G. Bakris, I. Hirsch, K. Kalantar-Zadeh, 2014 .

Kidney disease and increased mortality risk in type 2 diabetes.

B. Kestenbaum, I. D. de Boer, I. Hirsch, 2013, Journal of the American Society of Nephrology : JASN.

Living With Diabetes Project : Draft Final Project Report to the Center for Health Management Research

J. Ralston, I. Hirsch, A. Cheadle, 2004 .

Euglycemic Diabetic Ketoacidosis: A Potential Complication of Treatment With Sodium–Glucose Cotransporter 2 Inhibition

I. Hirsch, J. Buse, A. Peters, 2015, Diabetes Care.

The contribution of malglycemia to mortality among allogeneic hematopoietic cell transplant recipients.

I. Hirsch, M. Boeckh, M. Hammer, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Nonhypoglycemic drug reactions of agents used to treat diabetes.

I. Hirsch, J. A. White, 2000, Endocrinology and metabolism clinics of North America.

Standards of Medical Care in Diabetes—2008

Silvio E. Inzucchi, Irl B. Hirsch, I. Hirsch, 2008, Diabetes Care.

Individualizing Glycemic Targets in Type 2 Diabetes Mellitus: Implications of Recent Clinical Trials

I. Hirsch, F. Ismail-Beigi, S. Genuth, 2011, Annals of Internal Medicine.

American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for developing a diabetes mellitus comprehensive care plan.

Irl B Hirsch, Kenneth L Jones, Lois Jovanovič, 2011, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

I. Hirsch, E. Renard, T. Klupa, 2021, Diabetologia.

Insulin-pump therapy for type 1 diabetes mellitus.

Irl B Hirsch, I. Hirsch, S. Edelman, 2012, The New England journal of medicine.

Perioperative Management of Surgical Patients with Diabetes Mellitus

J. McGill, P. White, I. Hirsch, 1991, Anesthesiology.

In-patient hyperglycemia--are we ready to treat it yet?

I. Hirsch, 2002, The Journal of clinical endocrinology and metabolism.

Role of Insulin in Management of Surgical Patients With Diabetes Mellitus

J. McGill, I. Hirsch, J B McGill, 1990, Diabetes Care.

Perioperative hyperglycemia and risk of adverse events among patients with and without diabetes.

David R Flum, Irl B Hirsch, D. Flum, 2015, Annals of surgery.

Insulin analogues

I. Hirsch, 2012, Reactions Weekly.

Relationship of family history of type 2 diabetes, hypoglycemia, and autoantibodies to weight gain and lipids with intensive and conventional therapy in the Diabetes Control and Complications Trial.

J. Hokanson, I. Hirsch, P. Cleary, 2003, Diabetes.

Intensive Insulin Therapy for Treatment of Type I Diabetes

Irl B Hirsch, Jay S Skyler, I. Hirsch, 1990, Diabetes Care.

CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2020 EXECUTIVE SUMMARY.

J. Garber, J. McGill, R. DeFronzo, 2020, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2019 EXECUTIVE SUMMARY.

J. Garber, J. McGill, R. DeFronzo, 2019, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2017 EXECUTIVE SUMMARY.

J. Garber, J. McGill, R. DeFronzo, 2017, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM--2016 EXECUTIVE SUMMARY.

Irl B Hirsch, Janet B McGill, Lawrence Blonde, 2016, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

A Real-World Approach to Insulin Therapy in Primary Care Practice

I. Hirsch, R. Bergenstal, J. Buse, 2005 .

Culinary Medicine: Advancing a Framework for Healthier Eating to Improve Chronic Disease Management and Prevention.

Alison B. Evert, J. McGill, D. Kaufer, 2019, Clinical therapeutics.

Effect of Liraglutide on Times in Glycaemic Ranges as Assessed by CGM for Type 2 Diabetes Patients Treated With Multiple Daily Insulin Injections

I. Hirsch, J. Tuomilehto, B. Ahrén, 2019, Diabetes Therapy.

Targeting beta-cell function early in the course of therapy for type 2 diabetes mellitus.

J. Leahy, K. Peterson, I. Hirsch, 2010, The Journal of clinical endocrinology and metabolism.

American Association of Clinical Endocrinologists Medical Guidelines for clinical practice for developing a diabetes mellitus comprehensive care plan: executive summary.

Irl B Hirsch, Kenneth L Jones, Lois Jovanovič, 2011, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes. U.S. Study Group of Insulin Glargine in Type 1 Diabetes.

I. Hirsch, S. Garg, R. Ratner, 2000, Diabetes care.

Trends in the Endocrinology Fellowship Recruitment: Reasons for Concern and Possible Interventions

I. Hirsch, R. Gabbay, G. Romeo, 2020, The Journal of clinical endocrinology and metabolism.

Pharmacotherapies for diabetes management: an update for the practicing clinician.

I. Hirsch, L. Meneghini, 2006, Seminars in thoracic and cardiovascular surgery.

Effect of insulin therapy on nonglycemic variables during acute illness.

I. Hirsch, 2004, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Brain Glucose Sensing and the Problem of Relative Hypoglycemia.

I. Hirsch, M. Brownlee, J. Krinsley, 2023, Diabetes care.

Diabetes and heart failure: is insulin therapy the answer?

I. Hirsch, W. Levy, 2003, Journal of the American College of Cardiology.

Hospital management of diabetes.

I. Hirsch, E. Moghissi, 2005, Endocrinology and metabolism clinics of North America.

Beyond hemoglobin A1c--need for additional markers of risk for diabetic microvascular complications.

I. Hirsch, M. Brownlee, 2010, JAMA.

AACE/ACE comprehensive diabetes management algorithm 2015.

J. Garber, J. McGill, I. Hirsch, 2015, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Glycemic variability: a hemoglobin A1c-independent risk factor for diabetic complications.

Michael Brownlee, Irl B Hirsch, I. Hirsch, 2006, JAMA.

Glycemic Variability Percentage: A Novel Method for Assessing Glycemic Variability from Continuous Glucose Monitor Data

Thomas A. Peyser, Bruce A. Buckingham, Arturo Garcia, 2018, Diabetes technology & therapeutics.

Is A1C the Best Measure of Glycemic Control

I. Hirsch, C. Parkin, 2005 .

Serum Urate Lowering with Allopurinol and Kidney Function in Type 1 Diabetes.

J. McGill, I. D. de Boer, A. Galecki, 2020, The New England journal of medicine.

Web-based collaborative care for type 1 diabetes: a pilot randomized trial.

Irl B Hirsch, Diane P. Martin, James D Ralston, 2009, Diabetes technology & therapeutics.

Web-Based Collaborative Care for Type 2 Diabetes

James D. Ralston, Harold I. Goldberg, Allen Cheadle, 2009, Diabetes Care.

Incorporating Site-less Clinical Trials Into Drug Development: A Framework for Action.

D. Kaufer, E. Dorsey, I. Hirsch, 2017, Clinical therapeutics.

Glycemic Metrics and Targets in Kidney Disease

I. Hirsch, Joshua J. Neumiller, 2019, Endocrine Disorders in Kidney Disease.

Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes: A Randomized Clinical Trial.

J. McGill, R. Beck, M. Rickels, 2020, JAMA.

Clinically significant cognitive impairment in older adults with type 1 diabetes.

I. Hirsch, L. Germine, C. Ryan, 2019, Journal of diabetes and its complications.

Risk Factors Associated With Severe Hypoglycemia in Older Adults With Type 1 Diabetes

R. Beck, M. Rickels, I. Hirsch, 2015, Diabetes Care.

American Association of Clinical Endocrinologists’ Comprehensive Diabetes Management Algorithm 2013 Consensus Statement

J. McGill, I. Hirsch, G. Grunberger, 2013 .

Clinical application of emerging sensor technologies in diabetes management: consensus guidelines for continuous glucose monitoring (CGM).

Howard Wolpert, William L Clarke, Bruce Buckingham, 2008, Diabetes technology & therapeutics.

Sertraline for prevention of depression recurrence in diabetes mellitus: a randomized, double-blind, placebo-controlled trial.

K. Freedland, J. McGill, A. Gelenberg, 2006, Archives of general psychiatry.

The effects of improved glycemic control on complications in type 2 diabetes.

I. Hirsch, B. Gaster, 1998, Archives of internal medicine.

Role of Continuous Glucose Monitoring in Clinical Trials: Recommendations on Reporting.

Philip Home, Irl B Hirsch, Oliver Schnell, 2017, Diabetes technology & therapeutics.

Treatment of Diabetes in Older Adults: An Endocrine Society* Clinical Practice Guideline.

J. Halter, A. Sinclair, I. Hirsch, 2019, The Journal of clinical endocrinology and metabolism.

Why Are We Failing to Address the Issue of Access to Insulin? A National and Global Perspective

I. Hirsch, J. Yudkin, D. Beran, 2018, Diabetes Care.

AACE/ACE POSITION STATEMENT ON THE USE OF FOLLOW-ON BIOLOGICS AND BIOSIMILARS FOR ENDOCRINE DISEASES.

I. Hirsch, G. Grunberger, G. Umpierrez, 2017, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

35th Annual meeting of the European Association for the Study of Diabetes. Brussels, Belgium, 28 September-2 October, 1999. Abstracts.

Thomas J. Smith, B. M. Rasmussen, V. C. Phan, 1999, Diabetologia.

Management of Hyperglycemia in Diabetic Kidney Disease

I. Hirsch, Joshua J. Neumiller, 2015, Diabetes Spectrum.

Reexamining metrics for glucose control.

I. Hirsch, K. Rubinow, 2011, JAMA.

Trends in Glycemic Control Among Youth and Young Adults With Diabetes: The SEARCH for Diabetes in Youth Study.

Amy S. Shah, K. Reynolds, M. Rewers, 2022, Diabetes care.

Intensive Diabetes Treatment and Cardiovascular Outcomes in Type 1 Diabetes Mellitus: Implications of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study 30-Year Follow-up.

I. Hirsch, S. Subramanian, 2017, Endocrinology and metabolism clinics of North America.

Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. The effect of continuous glucose monitoring in well-controlled type 1 diabetes

Howard Wolpert, Michael J. O'Grady, Bruce A. Buckingham, 2009 .

Clinical review: Realistic expectations and practical use of continuous glucose monitoring for the endocrinologist.

Irl B. Hirsch, I. Hirsch, 2009, The Journal of clinical endocrinology and metabolism.

Continuous Glucose Monitoring and Intensive Treatment of Type 1 Diabetes The Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group

Howard Wolpert, Bruce Buckingham, Tim Wysocki, 2008 .

Continuous glucose monitoring to Assess glycemia in chroNic kiDneY disease – ChANging glucosE management

I. Hirsch, K. Tuttle, Joshua J. Neumiller, 2018 .

Insulin in the Hospital Setting

I. Hirsch, 2002 .

A Path Model of Chronic Stress, the Metabolic Syndrome, and Coronary Heart Disease

I. Hirsch, I. Siegler, P. Vitaliano, 2002, Psychosomatic medicine.

The majority of people with type 1 diabetes and multiple daily insulin injections benefit from using continuous glucose monitoring: An analysis based on the GOLD randomized trial (GOLD‐5)

W. Polonsky, I. Hirsch, T. Heise, 2020, Diabetes, obesity & metabolism.

Associations between HbA1c and continuous glucose monitoring‐derived glycaemic variables

P. Calhoun, I. Hirsch, D. Price, 2019, Diabetic medicine : a journal of the British Diabetic Association.

Design of FLAT-SUGAR: Randomized Trial of Prandial Insulin Versus Prandial GLP-1 Receptor Agonist Together With Basal Insulin and Metformin for High-Risk Type 2 Diabetes

B. Davis, I. Hirsch, R. Bergenstal, 2015, Diabetes Care.

Lowering targets for hemoglobin A1c in children with type 1 diabetes: raising the bar

I. Hirsch, T. Danne, D. Schatz, 2015, Pediatric diabetes.

Insulin Degludec/Insulin Aspart Administered Once Daily at Any Meal, With Insulin Aspart at Other Meals Versus a Standard Basal-Bolus Regimen in Patients With Type 1 Diabetes

I. Hirsch, B. Bode, A. King, 2012, Diabetes Care.

Diabetes and Driving

Michael A. Greene, D. Marrero, I. Hirsch, 2011, Diabetes Care.

Home Blood Glucose Monitoring in Type 2 Diabetes

I. Hirsch, 2011, Diabetes Care.

K. Freedland, I. Hirsch, R. Clouse, 2005, Psychosomatic Medicine.

Self-Monitoring of Blood Glucose

I. Hirsch, S. Garg, 1994, Diabetes Care.

Higher Prevalence of Elevated Albumin Excretion in Youth With Type 2 Than Type 1 Diabetes

D. Maahs, I. Hirsch, B. Snively, 2007, Diabetes Care.

New oral therapies for type 2 diabetes.

I. Hirsch, J. Purnell, 1997, American family physician.

Health Care Spending on Diabetes in the U.S., 1996–2013

I. Hirsch, H. Duber, A.E. Reynolds, 2018, Diabetes Care.

Glycaemic management in diabetes: old and new approaches.

I. Hirsch, M. Phillip, T. Battelino, 2021, The lancet. Diabetes & endocrinology.

CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM--2015 EXECUTIVE SUMMARY.

J. Garber, J. McGill, I. Hirsch, 2015, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

American Association of Clinical Endocrinologists' comprehensive diabetes management algorithm 2013 consensus statement--executive summary.

J. McGill, I. Hirsch, G. Grunberger, 2013, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Real-time CGM (rtCGM) during the COVID-19 Pandemic and its Impact on Time in Range.

Joost H. van der Linden, I. Hirsch, S. Garg, 2021, Diabetes technology & therapeutics.

Sulphonylurea–metformin combination therapy, cardiovascular disease and all‐cause mortality: the Fremantle Diabetes Study

I. Hirsch, W. Davis, B. Sillars, 2010, Diabetes, obesity & metabolism.

Metrics Beyond Hemoglobin A1C in Diabetes Management: Time in Range, Hypoglycemia, and Other Parameters

I. Hirsch, L. Wright, 2017, Diabetes technology & therapeutics.

A Short-Acting GLP-1 Analog or Prandial Insulin to Supplement Basal Insulin?—Moving Toward Personalized Management of Type 2 Diabetes Mellitus

Aaron M. King, W. Polonsky, I. Hirsch, 2014, Postgraduate medicine.

Time to Follow the Evidence: Glycemic control and cardiovascular benefits of new diabetes medications.

I. Hirsch, B. Draznin, 2021, The American journal of medicine.

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY 2016 OUTPATIENT GLUCOSE MONITORING CONSENSUS STATEMENT.

Bruce W Bode, Irl B Hirsch, David Rodbard, 2016, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Diabetic Kidney Disease: Is There a Role for Glycemic Variability?

I. Hirsch, S. Subramanian, 2018, Current Diabetes Reports.

Predictors and correlates of systolic blood pressure reduction with liraglutide treatment in patients with type 2 diabetes

J. Tuomilehto, I. Hirsch, O. Torffvit, 2018, Journal of clinical hypertension.

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY--CLINICAL PRACTICE GUIDELINES FOR DEVELOPING A DIABETES MELLITUS COMPREHENSIVE CARE PLAN--2015--EXECUTIVE SUMMARY.

G. Bray, J. McGill, I. Hirsch, 2015, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

3. Glycemic Management of Type 2 Diabetes

I. Hirsch, 2011 .

Response to Comment on the FLAT-SUGAR Trial Investigators. Glucose Variability in a 26-Week Randomized Comparison of Mealtime Treatment With Rapid-Acting Insulin Versus GLP-1 Agonist in Participants With Type 2 Diabetes at High Cardiovascular Risk. Diabetes Care 2016;39:973–981

I. Hirsch, J. Probstfield, M. Riddle, 2016, Diabetes Care.

Urinary excretion of RAS, BMP, and WNT pathway components in diabetic kidney disease

I. D. de Boer, I. Hirsch, J. Himmelfarb, 2014, Physiological reports.

Higher Glycemic Thresholds for Symptoms During β-Adrenergic Blockade in IDDM

I. Hirsch, P. Cryer, S. Craft, 1991, Diabetes.

A Randomized Clinical Trial of the Effect of Continuous Glucose Monitoring on Nocturnal Hypoglycemia, Daytime Hypoglycemia, Glycemic Variability, and Hypoglycemia Confidence in Persons with Type 1 Diabetes Treated with Multiple Daily Insulin Injections (GOLD-3)

Sofia Dahlqvist, Marcus Lind, Hans Wedel, 2018, Diabetes technology & therapeutics.

The Association Between HbA1c and Time in Hypoglycemia During CGM and Self-Monitoring of Blood Glucose in People With Type 1 Diabetes and Multiple Daily Insulin Injections: A Randomized Clinical Trial (GOLD-4)

W. Polonsky, I. Hirsch, T. Heise, 2020, Diabetes Care.

Interpersonal predictors of HbA(1c) in patients with type 1 diabetes.

W. Katon, I. Hirsch, P. Ciechanowski, 2002, Diabetes care.

Interpersonal Predictors of Hba 1c in Patients with Type 1 Diabetes O R I G I N a L a R T I C L E

W. Katon, I. Hirsch, P. Ciechanowski, 2022 .

A clinical trial of the accuracy and treatment experience of the Dexcom G4 sensor (Dexcom G4 system) and Enlite sensor (guardian REAL-time system) tested simultaneously in ambulatory patients with type 1 diabetes.

Sofia Dahlqvist, Irl B Hirsch, David Klonoff, 2014, Diabetes technology & therapeutics.

Long QT syndrome during high-dose cisapride.

W. A. Murray, I. Hirsch, J. P. Palmer, 1995, Archives of internal medicine.

The Management of Type 1 Diabetes

I. Hirsch, J. Skyler, 2013 .

Consensus Reports

Lee C. Rogers, William H. Herman, Kirkman, 2011, Diabetes Care.

Interference of Intravenous Vitamin C With Blood Glucose Testing

I. Hirsch, S. Vasudevan, 2014, Diabetes Care.

Design and Methods of a Randomized Trial of Continuous Glucose Monitoring in Persons With Type 1 Diabetes With Impaired Glycemic Control Treated With Multiple Daily Insulin Injections (GOLD Study)

W. Polonsky, I. Hirsch, T. Heise, 2016, Journal of diabetes science and technology.

Factors Predictive of Use and of Benefit From Continuous Glucose Monitoring in Type 1 Diabetes

Howard Wolpert, H Peter Chase, Roy W Beck, 2009, Diabetes Care.

Statement by the American Association of Clinical Endocrinologists Consensus Panel on continuous glucose monitoring.

I. Hirsch, L. Jovanovič, S. Garg, 2010, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

AACE Consensus Statement

I. Hirsch, L. Jovanovič, S. Garg, 2010 .

American Association of Clinical Endocrinology Consensus Statement: Comprehensive Type 2 Diabetes Management Algorithm - 2023 Update.

I. Hirsch, L. Blonde, G. Umpierrez, 2023, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

The relationship of depressive symptoms to symptom reporting, self-care and glucose control in diabetes.

Irl B Hirsch, W. Katon, I. Hirsch, 2003, General hospital psychiatry.

Continuous glucose monitoring and metrics for clinical trials: an international consensus statement.

M. Phillip, R. Beck, J. Rosenstock, 2022, The lancet. Diabetes & endocrinology.

New insulin infusion protocol Improves blood glucose control in hospitalized patients without increasing hypoglycemia.

I. Hirsch, J. Kelly, C. Sayre, 2005, Joint Commission journal on quality and patient safety.

Glucose Variability in a 26-Week Randomized Comparison of Mealtime Treatment With Rapid-Acting Insulin Versus GLP-1 Agonist in Participants With Type 2 Diabetes at High Cardiovascular Risk

Dejian Lai, Barry R. Davis, Kelley R. Branch, 2016, Diabetes Care.

Real‐time continuous glucose monitoring in type 1 diabetes: a systematic review and individual patient data meta‐analysis

Fares Alahdab, I. Hirsch, Zhen Wang, 2017, Clinical endocrinology.

Hypoglycemic Accuracy and Improved Low Glucose Alerts of the Latest Dexcom G4 Platinum Continuous Glucose Monitoring System.

Irl B Hirsch, I. Hirsch, D. Price, 2015, Diabetes technology & therapeutics.

Glucose time in range and peripheral neuropathy in type 2 diabetes mellitus and chronic kidney disease

I. D. de Boer, I. Hirsch, N. Bansal, 2020, BMJ Open Diabetes Research & Care.

High-dose insulin therapy: is it time for U-500 insulin?

I. Hirsch, J. Scism-Bacon, J. Skyler, 2009, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Non‐insulin treatments for Type 1 diabetes: critical appraisal of the available evidence and insight into future directions

I. Hirsch, L. Wright, 2019, Diabetic medicine : a journal of the British Diabetic Association.

Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 Diabetes

B. Buckingham, I. Hirsch, R. Bergenstal, 2021, Diabetes Care.

Does Type 1 Diabetes Affect Male Infertility: Type 1 Diabetes Exchange Registry-Based Analysis

I. Hirsch, M. Hehemann, O. Raheem, 2021 .

Inequities in Diabetic Ketoacidosis Among Patients With Type 1 Diabetes and COVID-19: Data From 52 US Clinical Centers

I. Hirsch, S. Agarwal, Nudrat Noor, 2020, The Journal of clinical endocrinology and metabolism.

COVID-19 Hospitalization in Adults with Type 1 Diabetes: Results from the T1D Exchange Multi-Center Surveillance Study

I. Hirsch, M. Tansey, S. Agarwal, 2020, The Journal of clinical endocrinology and metabolism.

New Medications for the Treatment of Diabetes.

I. Hirsch, Satish K Garg, Erika Rodriguez, 2023, Diabetes technology & therapeutics.

Options for prandial glucose management in type 2 diabetes patients using basal insulin: addition of a short‐acting GLP‐1 analogue versus progression to basal‐bolus therapy

J. McGill, J. Leahy, R. Rubin, 2014, Diabetes, obesity & metabolism.

Glycemic variability: it's not just about A1C anymore!

Irl B Hirsch, I. Hirsch, 2005, Diabetes technology & therapeutics.

Efficacy and Safety of Technosphere Inhaled Insulin Compared With Technosphere Powder Placebo in Insulin-Naive Type 2 Diabetes Suboptimally Controlled With Oral Agents

D. Klonoff, R. DeFronzo, J. Rosenstock, 2008, Diabetes Care.

Diabetes management in special situations.

I. Hirsch, D. Paauw, 1997, Endocrinology and metabolism clinics of North America.

Malglycemia in the critical care setting. Part I: Defining hyperglycemia in the critical care setting using the glycemic ratio.

I. Hirsch, G. Umpierrez, M. Brownlee, 2023, Journal of critical care.

Improvements in our understanding of diabetes mellitus.

I. Hirsch, 2013, Mayo Clinic proceedings.

CHAPTER 19 – MEDICAL MANAGEMENT OF PATIENTS WITH DIABETES MELLITUS DURING THE PERIOPERATIVE PERIOD

I. Hirsch, J. Kelly, 2008 .

Implementing an intravenous insulin protocol in your practice: practical advice to overcome clinical, administrative, and financial barriers.

I. Hirsch, A. Furnary, J. Kelly, 2006, Seminars in thoracic and cardiovascular surgery.

American College of Endocrinology position statement on inpatient diabetes and metabolic control.

I. Hirsch, N. Clark, A. Garber, 2004, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Diabetes Technology-Continuous Subcutaneous Insulin Infusion Therapy and Continuous Glucose Monitoring in Adults: An Endocrine Society Clinical Practice Guideline.

Alison B. Evert, I. Hirsch, M. Murad, 2016, The Journal of clinical endocrinology and metabolism.

Real-Time Continuous Glucose Monitoring Among Participants in the T1D Exchange Clinic Registry

David M. Maahs, Saleh Adi, Irl B. Hirsch, 2014, Diabetes Care.

Mark S. Anderson, J. McGill, I. Hirsch, 2023, AACE Clinical Case Reports.

SAFETY AND EFFICACY OF PERSONALIZED GLYCEMIC CONTROL IN CRITICALLY ILL PATIENTS: A 2-YEAR BEFORE AND AFTER INTERVENTIONAL TRIAL.

I. Hirsch, J. Preiser, J. Krinsley, 2017, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Utility of Technology in the Treatment of Type 1 Diabetes: Current State of the Art and Precision Evidence

I. Hirsch, M. Hulsman, M. Redondo, 2023, medRxiv.

Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46:384-390.

I. Hirsch, M. Endo, M. Roth, 2023, Diabetes care.

Hyperglycemic crises in diabetes mellitus type 2.

I. Hirsch, D. Trence, 2001, Endocrinology and metabolism clinics of North America.

Flash CGM Is Associated With Reduced Diabetes Events and Hospitalizations in Insulin-Treated Type 2 Diabetes

I. Hirsch, R. Bergenstal, Y. Nabutovsky, 2021, Journal of the Endocrine Society.

Erratum. Why Are We Failing to Address the Issue of Access to Insulin? A National and Global Perspective. Diabetes Care 2018;41:1125–1131

I. Hirsch, J. Yudkin, D. Beran, 2018, Diabetes Care.

Rates of Cardiac Rhythm Abnormalities in Patients with CKD and Diabetes.

I. D. de Boer, I. Hirsch, N. Bansal, 2019, Clinical journal of the American Society of Nephrology : CJASN.

Persistence of Individual Variations in Glycated Hemoglobin

Darrell M. Wilson, R. Beck, I. Hirsch, 2011, Diabetes Care.

Using multiple measures of glycemia to support individualized diabetes management: recommendations for clinicians, patients, and payers.

I. Hirsch, S. Amiel, B. Bode, 2012, Diabetes Technology & Therapeutics.

GLP-1 agonists in type 1 diabetes.

I. Hirsch, S. Edelman, J. Pettus, 2013, Clinical immunology.

Consensus Recommendations for the Use of Automated Insulin Delivery Technologies in Clinical Practice

C. de Beaufort, C. Cobelli, R. Hovorka, 2022, Endocrine reviews.

Individualizing Care for the Many

Bruce W Bode, Irl B Hirsch, I. Hirsch, 2010, The Diabetes educator.

What is innovation in the area of medicines? The example of insulin and diabetes

I. Hirsch, J. Yudkin, D. Beran, 2019, Diabetic medicine : a journal of the British Diabetic Association.

Insulin glargine and cancer--an unsubstantiated allegation.

I. Hirsch, S. Garg, J. Skyler, 2009, Diabetes technology & therapeutics.

Qualitative evaluation of a mobile phone and web-based collaborative care intervention for patients with type 2 diabetes.

Jan Flowers, Irl B Hirsch, James Hoath, 2011, Diabetes technology & therapeutics.

Introduction: History of Glucose Monitoring

I. Hirsch, 2018, Role of Continuous Glucose Monitoring in Diabetes Treatment.

Case-control Investigation of Previously Undiagnosed Diabetes in the Critically Ill

I. Hirsch, G. Umpierrez, M. Brownlee, 2022, Journal of the Endocrine Society.

Professional flash continuous glucose monitoring as a supplement to A1C in primary care

I. Hirsch, 2017, Postgraduate medicine.

Intensive treatment of type 1 diabetes.

I. Hirsch, 1998, The Medical clinics of North America.

A Simple Composite Metric for the Assessment of Glycemic Status from Continuous Glucose Monitoring Data: Implications for Clinical Practice and the Artificial Pancreas.

Bruce A Buckingham, Irl B Hirsch, Arturo Garcia, 2017, Diabetes technology & therapeutics.

Frequency of blood glucose monitoring in relation to glycemic control in patients with type 2 diabetes.

I. Hirsch, L. Blonde, S. Horn, 2002, Diabetes care.

A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings

Francis J. Doyle, G. A. Fleming, B. Bequette, 2022, Journal of diabetes science and technology.

Type 1 diabetes mellitus and the use of flexible insulin regimens.

I. Hirsch, 1999, American family physician.

Serum cystatin C in youth with diabetes: The SEARCH for diabetes in youth study.

K. Reynolds, D. Maahs, I. Hirsch, 2017, Diabetes research and clinical practice.

Hypoglycemia in People with Type 2 Diabetes and CKD.

I. D. de Boer, I. Hirsch, N. Bansal, 2019, Clinical journal of the American Society of Nephrology : CJASN.

Patient factors associated with glucagonlike peptide 1 receptor agonist use with and without insulin.

I. Hirsch, K. Davis, B. Calingaert, 2011, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Motherhood, apple pie, hemoglobin A(1C), and the DCCT.

I. Hirsch, D. Trence, 2012, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Clinical decisions. Glycemic management in a patient with type 2 diabetes.

Mark E Molitch, Irl B Hirsch, I. Hirsch, 2013, The New England journal of medicine.

Animal insulin therapy induces a biased insulin antibody response that persists for years after introduction of human insulin

I. Hirsch, C. Hampe, S. Oak, 2010, Acta Diabetologica.

Hemoglobin A1c and Mean Glucose in Patients With Type 1 Diabetes

Darrell M. Wilson, R. Beck, I. Hirsch, 2011, Diabetes Care.

Using the continuous glucose monitoring system to improve the management of type 1 diabetes.

I. Hirsch, B. Bode, 2000, Diabetes technology & therapeutics.

In Response to Carter and Heinemann: Insulin Concentration in Vials Randomly Purchased in Pharmacies in the United States: Considerable Loss in the Cold Supply Chain

Irl B Hirsch, Jay S Skyler, I. Hirsch, 2018, Journal of diabetes science and technology.

Improved Glycemia with Hybrid Closed-Loop (HCL) Versus Continuous Subcutaneous Insulin Infusion (CSII) Therapy: Results from a Randomized Controlled Trial.

Gregory P. Forlenza, J. McGill, M. Lawson, 2022, Diabetes technology & therapeutics.

Interference of home blood glucose measurements and poor outcomes: a solvable problem requiring broader exposure.

I. Hirsch, C. A. Verderese, 2010, Diabetes technology & therapeutics.

Sliding scale insulin--time to stop sliding.

I. Hirsch, 2009, JAMA.

Continuous subcutaneous insulin infusion (CSII) of insulin aspart versus multiple daily injection of insulin aspart/insulin glargine in type 1 diabetic patients previously treated with CSII.

I. Hirsch, S. Garg, B. Bode, 2005, Diabetes care.

Connecting the Dots: Validation of Time in Range Metrics With Microvascular Outcomes

I. Hirsch, K. Hood, J. Sherr, 2019, Diabetes Care.

Using Insulin to Treat Poorly Controlled Type 2 Diabetes in 2020.

I. Hirsch, L. Gaudiani, 2020, JAMA.

Increased symptoms of hypoglycaemia in the standing position in insulin-dependent diabetes mellitus.

I. Hirsch, P. Cryer, S. Heller, 1991, Clinical science.

TAKOTSUBO CARDIOMYOPATHY IN ASSOCIATION WITH DKA IN A BLIND PUMP PATIENT

I. Hirsch, Jedidiah Meyers, 2017 .

Type 2 diabetes: the role of basal insulin therapy.

I. Hirsch, D. Leroith, M. Riddle, 2004, Journal of Family Practice.

Diabetes and Driving

Michael A. Greene, D. Marrero, D. Cox, 2013, Diabetes Care.

Characteristics of CGM metrics in persons with type 1 and type 2 diabetes treated with multiple daily insulin injections.

I. Hirsch, A. Svensson, M. Lind, 2021, Diabetes technology & therapeutics.

Advanced Technologies and Treatments for Diabetes Internet and information technology use in treatment of diabetes

N. Kaufman, J. Ralston, I. Hirsch, 2010 .

49. Insulin pumps

I. Hirsch, D. Trence, I. B. Hirsch, 2015 .

Hyperglycemic Emergencies: What Primary Care Providers Need to Know

I. Hirsch, 2001 .

REPLACE-BG: A Randomized Trial Comparing Continuous Glucose Monitoring With and Without Routine Blood Glucose Monitoring in Adults With Well-Controlled Type 1 Diabetes

R. Beck, M. Rickels, C. Kollman, 2017, Diabetes Care.

Insulin Strategies for Primary Care Providers

Irl B. Hirsch, I. Hirsch, K. Herbst, 2002 .

The Effect of Continuous Glucose Monitoring in Well-Controlled Type 1 Diabetes

Michael J. O'Grady, Darrell M. Wilson, R. Beck, 2009, Diabetes Care.

Coverage for Continuous Glucose Monitoring for Individuals with Type 2 Diabetes Treated with Nonintensive Therapies: An Evidence-Based Approach to Policymaking

J. McGill, I. Hirsch, G. Grunberger, 2023, Diabetes technology & therapeutics.

Comparing clinical outcomes between two continuous glucose monitors: similar diabetes-related events, all-cause hospitalizations and HbA1c reductions in type 1 and type 2 diabetes

I. Hirsch, Y. Nabutovsky, Ignacio J. Reyes, 2022, American Journal of Medicine Open.

Multicenter, Randomized Trial of a Bionic Pancreas in Type 1 Diabetes.

Kristen M. Williams, J. Keith Jones, P. Raskin, 2022, The New England journal of medicine.

Early Trajectory of Estimated Glomerular Filtration Rate and Long-term Advanced Kidney and Cardiovascular Complications in Type 1 Diabetes.

B. Zinman, I. D. de Boer, I. Hirsch, 2022, Diabetes Care.

ATTACHMENT STYLE AND ADHERENCE IN THE DIABETIC PATIENT

W. Katon, I. Hirsch, P. Ciechanowski, 1999 .

Brief Commentary: Confusing Treatment Guidelines for Patients With Type 2 Diabetes

I. Hirsch, J. Skyler, 2018, Annals of Internal Medicine.

Designing mobile support for glycemic control in patients with diabetes

Tung Le, Jan Flowers, James D. Ralston, 2010, J. Biomed. Informatics.

Design and methods of a randomised double-blind trial of adding liraglutide to control HbA1c in patients with type 2 diabetes with impaired glycaemic control treated with multiple daily insulin injections (MDI-Liraglutide trial).

J. Tuomilehto, I. Hirsch, O. Torffvit, 2015, Primary care diabetes.

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.

W. E. Sanabria, John A. Hamling, Ju Han Kim, 2019, Lancet.

Diabetes and Driving

Michael A. Greene, D. Marrero, I. Hirsch, 2011, Diabetes Care.

Preventing Early Renal Loss in Diabetes (PERL) Study: A Randomized Double-Blinded Trial of Allopurinol—Rationale, Design, and Baseline Data

J. McGill, A. Galecki, A. Goldfine, 2019, Diabetes Care.

AACE Consensus Statement

I. Hirsch, E. Orzeck, Elizabeth Nardacci, 2010 .

Clinical Implications of Real-time and Intermittently Scanned Continuous Glucose Monitoring

I. Hirsch, S. Edelman, N. Argento, 2018, Diabetes Care.

Insulin analogues: new agents for improving glycemic control.

I. Hirsch, R. Campbell, John R. White, 1997, Postgraduate medicine.

The Impact of Inpatient Point‐Of‐Care Blood Glucose Quality Control Testing

I. Hirsch, J. Whitney, A. Hoofnagle, 2011, Journal for healthcare quality : official publication of the National Association for Healthcare Quality.

The Hybrid Closed-Loop System: Evolution and Practical Applications.

Irl B Hirsch, I. Hirsch, Kathryn W Weaver, 2018, Diabetes technology & therapeutics.

Treatment of Diabetes in Older Adults: An Endocrine Society* Clinical Practice Guideline.

J. Halter, A. Sinclair, I. Hirsch, 2019, The Journal of clinical endocrinology and metabolism.

Diabetes Technology-Continuous Subcutaneous Insulin Infusion Therapy and Continuous Glucose Monitoring in Adults: An Endocrine Society Clinical Practice Guideline.

Alison B. Evert, I. Hirsch, T. Battelino, 2016, The Journal of clinical endocrinology and metabolism.

Blood glucose control using a computer-guided glucose management system in allogeneic hematopoietic cell transplant recipients

M. Bar, I. Hirsch, R. Farah, 2016, Bone Marrow Transplantation.

AACE Consensus Statement

I. Hirsch, E. Orzeck, Elizabeth Nardacci, 2010 .

Surveillance for complications of diabetes: don't wait for symptoms before intervening.

I. Hirsch, 1996, Postgraduate medicine.

Weight and elevated albumin to creatinine ratio in youth with diabetes: the SEARCH for Diabetes in Youth study

D. Maahs, I. Hirsch, B. Snively, 2008, Pediatric Nephrology.

American Association of Clinical Endocrinologists' comprehensive diabetes management algorithm 2013 consensus statement--executive summary.

J. McGill, I. Hirsch, G. Grunberger, 2013, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Evaluation of Effects of Continuous Glucose Monitoring on Physical Activity Habits and Blood Lipid Levels in Persons With Type 1 Diabetes Managed With Multiple Daily Insulin Injections: An Analysis Based on the GOLD Randomized Trial (GOLD 8)

I. Hirsch, J. Bolinder, M. Wijkman, 2022, Journal of diabetes science and technology.

American association of clinical endocrinologists and american college of endocrinology - clinical practice guidelines for developing a diabetes mellitus comprehensive care plan - 2015.

G. Bray, J. McGill, I. Hirsch, 2015, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY 2016 OUTPATIENT GLUCOSE MONITORING CONSENSUS STATEMENT.

I. Hirsch, L. Jovanovič, W. Tamborlane, 2016, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

American Association of Clinical Endocrinologists and American Diabetes Association Consensus Statement on Inpatient Glycemic Control

I. Hirsch, F. Ismail-Beigi, G. Umpierrez, 2009, Diabetes Care.

American Association of Clinical Endocrinologists’ Comprehensive Diabetes Management Algorithm 2013 Consensus Statement

J. McGill, I. Hirsch, G. Grunberger, 2013, Endocrine Practice.

Title Diabetic kidney disease : a report from an ADA Consensus Conference

G. Bakris, I. Hirsch, K. Kalantar-Zadeh, 2014 .

Human Insulin for Type 2 Diabetes: An Effective, Less-Expensive Option.

I. Hirsch, K. Lipska, M. Riddle, 2017, JAMA.

Use of a "fuzzy logic" controller in a closed-loop artificial pancreas.

Irl B Hirsch, Robert Kircher, I. Hirsch, 2013, Diabetes technology & therapeutics.

Variables associated with HbA1c and weight reductions when adding liraglutide to multiple daily insulin injections in persons with type 2 diabetes (MDI Liraglutide trial 3)

J. Tuomilehto, I. Hirsch, T. Gustafsson, 2018, BMJ Open Diabetes Research & Care.

Assessing the Accuracy of Continuous Glucose Monitoring (CGM) Calibrated With Capillary Values Using Capillary or Venous Glucose Levels as a Reference

D. Klonoff, I. Hirsch, J. DeVries, 2016, Journal of diabetes science and technology.

Unaltered cerebral blood flow during hypoglycemic activation of the sympathochromaffin system in humans.

W. Powers, I. Hirsch, P. Cryer, 1993, The American journal of physiology.

Management of Type 1 Diabetes

I. Hirsch, J. Skyler, 2012 .

Multivariable adaptive identification and control for artificial pancreas systems

Irl B. Hirsch, I. Hirsch, J. Bollyky, 2015 .

Metrics Beyond Hemoglobin A1C in Diabetes Management: Time in Range, Hypoglycemia, and Other Parameters

I. Hirsch, L. Wright, 2017, Diabetes technology & therapeutics.

Costs Associated With Using Different Insulin Preparations.

I. Hirsch, T. Tylee, 2015, JAMA.

Diabetes and CKD in the United States Population, 2009-2014.

P. Heagerty, B. Kestenbaum, C. Robinson-Cohen, 2017, Clinical journal of the American Society of Nephrology : CJASN.

J. Tuomilehto, I. Hirsch, T. Gustafsson, 2019, Obesity science & practice.

Clinical Diabetes Centers of Excellence: A Model for Future Adult Diabetes Care

D. Harlan, I. Hirsch, R. Gabbay, 2018, The Journal of clinical endocrinology and metabolism.

The Impact of COVID-19 on CGM Use in the Hospital

Irl B. Hirsch, I. Hirsch, Nicole Ehrhardt, 2020, Diabetes Care.

Intensifying insulin therapy in patients with type 2 diabetes mellitus.

I. Hirsch, 2005, The American journal of medicine.

Continuous Glucose Monitoring: A Rapidly Evolving New Tool to Understand Pathophysiology and Enhance Clinical Care in CKD.

I. D. de Boer, I. Hirsch, 2023, Clinical journal of the American Society of Nephrology : CJASN.

Baseline risk markers and visit-to-visit variability in relation to kidney outcomes - a post-hoc analysis of the PERL study.

J. McGill, I. D. de Boer, T. Hansen, 2022, Diabetes research and clinical practice.

Associations of Biomarkers of Tubular Injury and Inflammation with Biopsy Features in Type 1 Diabetes

I. D. de Boer, I. Hirsch, S. Waikar, 2023, Clinical journal of the American Society of Nephrology : CJASN.

Improvements in our understanding of diabetes mellitus.

I. Hirsch, 2013, Mayo Clinic proceedings.

Impact of prandial plus basal vs basal insulin on glycemic variability in type 2 diabetic patients.

I. Hirsch, B. Campaigne, M. Tan, 2009, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Insulin in America: A Right or a Privilege?

I. Hirsch, 2016, Diabetes Spectrum.

Reexamining metrics for glucose control.

I. Hirsch, K. Rubinow, 2011, JAMA.